Literature DB >> 8005261

Prevention of occupational asthma.

K M Venables1.   

Abstract

This paper focuses on the prevention of asthma caused by exposure to sensitizing agents in the workplace. Control of exposure (primary prevention) is the most direct method of reducing the number of incident cases. Screening programmes are also necessary as a "safety net", and have value as secondary prevention, because early detection may improve long-term prognosis. It is recommended that regulatory or advisory bodies with responsibility for occupational asthma publish a guidance document on occupational asthma explaining their current concepts. Surveillance activities provide information on how common asthma is relative to other occupational lung diseases, and on the relative frequency of occurrence of asthma caused by different agents. Publication of a list of sensitizing agents would aid those with responsibility for control of exposure in the workplace. Epidemiological research on exposure-response relations is is necessary as a background to prevention. This paper recommends such studies. Immunotoxicological research also has a role in testing hypotheses that cannot be tested in human subjects. Some standardization of screening programmes in industry is desirable. A short symptoms questionnaire is economical and acceptable to workers, but there are other approaches. Finally, evaluative research on prevention measures gives information on their effectiveness and efficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005261     DOI: 10.1183/09031936.94.07040768

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Follow up investigation of workers in synthetic fibre plants with humidifier disease and work related asthma.

Authors:  T M Pal; J G de Monchy; J W Groothoff; D Post
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

2.  Detection of workers sensitised to high molecular weight allergens: a diagnostic study in laboratory animal workers.

Authors:  E Meijer; D E Grobbee; D Heederik
Journal:  Occup Environ Med       Date:  2002-03       Impact factor: 4.402

Review 3.  Occupational asthma. Practical points for diagnosis and management.

Authors:  W G Kuschner; R K Chitkara; P S Sarinas
Journal:  West J Med       Date:  1998-12

4.  Decreasing work disability from asthma.

Authors:  P Harber
Journal:  West J Med       Date:  1996-09

5.  Efficacy of measures of hygiene in workers sensitised to acid anhydrides and the influence of selection bias on the results.

Authors:  H Drexler; K H Schaller; J Nielsen; A Weber; M Weihrauch; H Welinder; S Skerfving
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

6.  Stepwise health surveillance for bronchial irritability syndrome in workers at risk of occupational respiratory disease.

Authors:  W K Post; K M Venables; D Ross; P Cullinan; D Heederik; A Burdorf
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

7.  A strategy for health surveillance in laboratory animal workers exposed to high molecular weight allergens.

Authors:  E Meijer; D E Grobbee; D Heederik
Journal:  Occup Environ Med       Date:  2004-10       Impact factor: 4.402

8.  Asthma-like symptoms, atopy, and bronchial responsiveness in furniture workers.

Authors:  D Talini; A Monteverdi; A Benvenuti; M Petrozzino; F Di Pede; M Lemmi; A Carletti; P Macchioni; N Serretti; G Viegi; P Paggiaro
Journal:  Occup Environ Med       Date:  1998-11       Impact factor: 4.402

9.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

10.  Chronic obstructive pulmonary disease (COPD) and occupational exposures.

Authors:  Piera Boschetto; Sonia Quintavalle; Deborah Miotto; Natalina Lo Cascio; Elena Zeni; Cristina E Mapp
Journal:  J Occup Med Toxicol       Date:  2006-06-07       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.